Xinyi Wang
机构:Nanchang University, University of Kentucky, Shandong University, Nanjing Forestry University, Xuzhou Medical College, Xi'an Shiyou University, Yunnan University, Lanzhou University of Technology, Markey Cancer Center, Beijing Forestry University, Jiangxi Provincial Academy of Medical Sciences, First Affiliated Hospital of Jiangxi Medical College, Guangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality, Second Affiliated Hospital of Nanchang University, Second Hospital of Nanchang, National Clinical Research, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Zhejiang Center for Disease Control and Prevention, Chinese Academy of Agricultural Sciences, Education Department of Jiangxi Province, Ministry of Agriculture and Rural Affairs, Institute of Crop Sciences, Heilongjiang University, Ocean University of China, Lanzhou University, Guangzhou Medical University, Nanchang Hangkong University, Zhongkai University of Agriculture and Engineering · ORCID:0009-0002-6349-8013
发表论文 326 篇 · 总被引 8187 次 · h-index 41
代表论文
- Heterojunction Engineering of MOFs and MXene on Melamine Foam Toward High‐Performance Microwave Absorption and Flame Retardancy (2025 · Small Structures · 被引 6)
- Design and Synthesis of a Bio‐Based DOPO ‐ ITA Flame‐Retardant Monomer for Modifying CO 2 ‐Based Polycarbonates (2025 · Journal of Polymer Science · 被引 2)
- Biological Age Acceleration and the Dynamic Progression of Cardiovascular‐Kidney‐Metabolic Diseases to Multimorbidity, Dementia and Mortality: A Prospective Cohort Study (2026 · Geriatrics and gerontology international/Geriatrics & gerontology international · 被引 1)
- The systemic immune-inflammation index in coronary heart disease: a narrative review of thromboinflammation, phenotype-dependent utility, and clinical translation (2026 · Frontiers in Cardiovascular Medicine · 被引 1)
- Cohort profile: Zhejiang Healthy Aging Cohort Study (ZHACS) (2026 · International Journal of Epidemiology · 被引 1)
- Targeting GRP78 and the Proteostasis Network to Break the Therapeutic Ceiling in Neuroendocrine Prostate Cancer (2026 · iNew Medicine · 被引 1)